CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research
暂无分享，去创建一个
D. Gomez | D. Alonso | Y. Perera | L. Betancourt | V. Besada | P. López-Saura | Aniel Sánchez | L. González | H. Garay | O. Reyes | Jeovanis Gil | S. Perea | B. Acevedo | H. Farina | I. García | I. Hernández | I. Baladrón | C. Valenzuela | J. Soriano | N. Batista | Luis Herrera | R. Gómez | Arielis Rodríguez | L. Castellanos | Matilde López | Yanelda García | Carlos A. González | L. González | A. López | A. Palau | M. Solares | Agueda Santana | M. Cruz | Alina Díaz | P. Perrin | Jean-Yves Renualt | Hugo Sigman | Boris E. Acevedo | Roberto E. Gómez